Last edition
News about "Padraig McDonnell"
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
Agilent Technologies reports strong third-quarter fiscal 2026 results and raises its FY26 revenue growth, margin expansion and non-GAAP EPS guidance.
Padraig McDonnell | 27/08/2026 | By News Bureau
Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities
Agilent Advanced Therapeutics offers CDMO services spanning oligonucleotides, microbial fermentation, complex chemistry, bioreagents, highly potent APIs, and cell line development, providing integrated end-to-end support from discovery and process development to clinical and commercial manufacturing.
Padraig McDonnell | 12/03/2026 | By News Bureau | 157
Agilent to Acquire Biocare Medical
Agilent Technologies has agreed to acquire Biocare Medical, expanding its pathology portfolio with complementary antibodies, reagents and instruments. The acquisition is expected to strengthen Agilent’s revenue growth, margin profile and non-instrument revenue mix from the first year.
Padraig McDonnell | 11/03/2026 | By News Bureau | 134
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy